Change of Leadership for the Esaote Group

The Shareholder’s Meeting of Esaote S.p.A. a leading Company in the sector of diagnostic imaging – held in Genoa under the Chairmanship of Mr. Wu Guangming, has reconstituted its Board of Directors, expiring upon the approval of the company’s financial statements at 31.12.2018.

At the Shareholders’ Meeting of Esaote S.p.A. took notice of the resignation submitted by the CEO of the Group Karl-Heinz Lumpi and has appointed the new Board of Directors composed by Wu Guangming – confirmed Chairman – Franco Fontana, Eugenio Biglieri, Xie Yufeng, e Zheng Hongzhe.

Change of leadership for the Esaote Group
Change of leadership for the Esaote Group: Franco Fontana new CEO

The Board of Directors has immediately appointed Franco Fontana to the role of Chief Executive Officer.

Franco Fontana – who holds a doctorate in Computer Science and telecommunications at the University of Genoa and subsequently an Executive MBA at SDA Bocconi of Milan – has matured more than twenty years of experience in software applied to medical imaging and healthcare IT along a professional career that started as an entrepreneur and evolved as an executive manager. He took the direction of the Business Unit of EBIT AET, belonging to Esaote Group since 2008. Under his leadership, the Medical IT PACS business is constantly growing year after year, and Ebit has become a market leader in Italy and consolidated its international presence in Europe, Latin America and APAC.

To support Franco in his new role, effective immediately, Eugenio Biglieri has been appointed to the new role of Chief Operating Officer, with responsibilities spanning across Research & Development, Manufacturing, Operations, Strategic Marketing, Quality & Regulatory, and servicing of Medical Systems. Eugenio Biglieri joined Esaote in 1985, and over the years he has covered positions of increasing responsibility up to hold the roles of MRI Marketing Director and Chief Global service Officer.

The Board of Directors wishes to express its heartfelt gratitude to Karl-Heinz Lumpi for his commitment over the years to the leadership of Esaote. Mr Lumpi will continue to provide support over the coming months to complete the latest applications planned for the MyLab9 family.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc.

Santa Casa Hospital System Chooses Carestream for a Unified Diagnostic Workflow

Santa Casa de Misericordia has selected Carestream to replace its legacy diagnostic workflow technology across all seven of its hospitals in Porto Alegre, the capital and largest city of the Brazilian state of Rio Grande do Sul.

American College of Cardiology Thanks Senators McConnell, Kaine for Efforts to Reduce Youth Tobacco...

On behalf of our patients, ACC members thank the Senators for their efforts to reduce youth tobacco use and stand ready to partner with them—and other members of Congress—to enact strong legislation establishing a federal age of 21 for the sale of all tobacco products.”

ResMed Study Finds CPAP Adherence Improved by Remote Monitoring, Self-Monitoring Across 3 Countries

ResMed reports the average adherence to PAP (positive airway pressure), the gold standard for treating sleep apnea, is approximately 50 percent when using legacy technology with no cloud connectivity or remote monitoring capabilities.

Life Image and Bialogics Analytics Partner to Enable Provider Organizations to Optimize Operations, Interoperability

The Life Image and Bialogics partnership will streamline access to analytics of medical imaging in order to help provider organizations enhance operational and financial performance, and improve patient satisfaction.

MediSpin XL™ – Cutting-Edge High-Volume Electrospinning Production Platform for Medical Devices is Launched

The launch of the MediSpin XL™ platform marks a global breakthrough in the controlled large-scale production of well-defined scaffolds for implants and membranes using fibers ranging from nanometer up to micrometer scale.

Hemodialysis Vascular Grafts Market Size Worth $276.5 Million By 2025

Increasing number of patients suffering from chronic kidney diseases (CKD) and growing adoption of biological access products due to technological advancements in the field are some of the factors contributing to revenue growth. Higher number of renal impaired patients and limited availability of suitable kidney donors are promoting hemodialysis procedures in renal impaired patients, which in turn is expected to fuel the demand for vascular grafts over the forecast period.